Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00359138
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2006-07-31
Brief Title:
The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation P04441
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Double-blind Double-dummy Parallel-group Placebo-controlled Randomized Study to Assess the Duration of the Suppressive Effects of Desloratadine on the Cutaneous Allergen-induced Wheal and Flare 1 Response After Discontinuation
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind double-dummy placebo-controlled parallel-group single center study in subjects with positive histamine skin prick test and a positive RadioAllergoSorbent Test RAST class 2 to one of the tested standardized allergenic extracts tree pollen cat dander house dust mite or a mixture of five grass pollens Subjects will be randomized to desloratadine 5 mg once daily levocetirizine 5mg once daily or placebo once daily for 8 days of treatment followed by 11 days of skin testing after discontinuation of the antihistamine treatment phase The duration of the suppressive effects of desloratadine on cutaneous allergen-induced wheal and flare responses after discontinuation of a one-week treatment will be established
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None